Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | +2.36% | +21.33% | +7.52% |
03-27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
03-26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Business Summary
Number of employees: 65
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 28/02/07 |
Founder | 59 | 28/02/07 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 31/12/10 |
Gerhard Frey
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/07 |
Cathy Chang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eric Sievers
CTO | Chief Tech/Sci/R&D Officer | 60 | 31/05/19 |
Scott Smith
BRD | Director/Board Member | 61 | 09/09/18 |
Susie Melody
HRO | Human Resources Officer | - | - |
Comptroller/Controller/Auditor | 48 | 31/10/15 | |
Mike Melnick
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 30/11/20 |
Jay Short
CEO | Chief Executive Officer | 66 | 28/02/07 |
Director/Board Member | 76 | 31/12/15 | |
Edward Williams
BRD | Director/Board Member | 68 | 15/12/21 |
Sylvia Mcbrinn
BRD | Director/Board Member | 71 | 14/06/21 |
Scott Smith
BRD | Director/Board Member | 61 | 09/09/18 |
Susan Moran
BRD | Director/Board Member | 54 | 30/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,096,717 | 43,366,546 ( 90.17 %) | 0 | 90.17 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.52% | 122M | |
+2.10% | 42.75B | |
+47.58% | 41.61B | |
+12.35% | 41.34B | |
-12.36% | 26.59B | |
+8.74% | 25.49B | |
-23.35% | 18.12B | |
+30.90% | 12.24B | |
-1.68% | 11.76B | |
+8.94% | 11B |
- Stock Market
- Equities
- BCAB Stock
- Company BioAtla, Inc.